Welcome to the summer edition of US Endocrinology! In this issue we present authoritative, up-to-date information on a wide range of salient topics including the pandemic of obesity, which is driving the diabetes epidemic across the globe, with developing countries especially bearing the brunt of this epidemic. We present four original articles addressing different issues of diabetes care and metabolism. Finally, we include two case studies, which are a valuable means of highlighting less common endocrine conditions such as non-autoimmune familial hyperthyroidism due to germline-activating mutations in the thyrotropin receptor gene, and management issues in an adolescent girl diagnosed with acromegaly due to McCune–Albright Syndrome.
A big thank you to all our expert authors, Editorial Board and society partners for their ongoing support and contributions.
Enjoy and happy reading!
Welcome to the summer edition of US Endocrinology. In this issue we present authoritative, up-to-date information on a wide range of salient topics. The pandemic of obesity is driving the diabetes epidemic across the globe, with developing countries especially bearing the brunt of this epidemic. We open with an editorial from Malkin-Washeim and Vogliano, where they […]
The prevalence of diabetes is on the rise globally, and with one in two adults remaining undiagnosed,1Â there is an urgency to broaden our services to include community partnerships. Extreme poverty is often found in remote areas where people are hard to reach, and have limited access to schools, healthcare, safe drinking water, and electricity. In […]
The diabetes pandemic affects millions of individuals throughout the world; the prevalence, especially of type 2 diabetes mellitus (T2DM), is increasing and shows no signs of abating. According to the International Diabetes Federation, the number of adults living with diabetes (both type 1 [T1DM] and T2DM) is projected to increase from 425 million in 2017 […]
Unmet needs for glucose monitoring in people with diabetes mellitus using intensive insulin Glucose monitoring is essential for people using intensive insulin to inform adjustments to the treatment and management of diabetes. Evidence suggests many people do not adhere to the recommended testing frequency with self-monitoring of blood glucose (SMBG). In the USA, it was […]
India, being an epicenter of diabetic population, faces increases in disease prevalence of more than double, every 15 years, and is projected to have about 123.5 million cases by the year 2040.1 In addition to achieving target glycated hemoglobin (HbA1c) <7%, intensive control of blood glucose levels is important in order to retard or arrest […]
India has a vast diversity of cultures and religions following a vast number of festivals and rituals irrespective of their caste, creed, age, and status with different rituals.1 The Hindu religion constitutes the world’s third largest religion and 80% of the Hindu population resides in India and Nepal.2 According to the All India Religion Census […]
In children, hyperthyroidism occurs less commonly compared to hypothyroidism, yet it is far more symptomatic.1 Hyperthyroidism in children is mostly due to autoimmunity, predominantly as a result of Graves’ disease.2 Non-autoimmune hyperthyroidism (NAH) is a rare cause of hyperthyroidism in children. The existence of a non-autoimmune form of goitrous hyperthyroidism was first hypothesized in 1982, […]
McCune–Albright syndrome (MAS) is a genetic disorder first described by McCune1 and Albright2 in the 1930s as a triad of polyostotic fibrous dysplasia, café-au-lait spots, and precocious puberty (Figure 1). Since then, other hyperfunctioning endocrinopathies have been described in MAS, including hyperthyroidism, Cushing’s syndrome, hypophosphatemic osteomalacia, and acromegaly.3 Patients with MAS display mosaicism as the disease results […]
Trending Topic
Welcome to the latest edition of touchREVIEWS in Endocrinology, which features a range of review, case report and original research articles that highlight some key developments in our understanding and management of endocrinological disease. We begin with a commentary from Eleni Armeni and Ashley Grossman on seliciclib, a potential new treatment for patients with Cushing’s […]
US Endocrinology is a peer-reviewed, free-to-access, bi-annual journal comprising review articles, case reports, editorials, special reports and original research. It features balanced and comprehensive articles written by leading authorities, addressing the most important and salient developments in the field of endocrinology.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.